Down-Regulated FOXO1 in Refractory/Relapse Childhood B-Cell Acute Lymphoblastic Leukemia

Background: Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, with an overall prevalence of 4/100,000, accounting for 25–30% of all childhood cancers. With advances in childhood ALL treatment, the cure rate for childhood ALL has exceeded 80% in most countries. However, refracto...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Qingqing Zheng, Chuang Jiang, Haiyan Liu, Wenge Hao, Pengfei Wang, Haiying Huang, Ziping Li, Jiabi Qian, Maoxiang Qian, Hui Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-11-01
Subjects:	acute lymphoblast leukemia risk stratification relapse FOXO1 MRD—minimal residual disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2020.579673/full